BioTerrorism Will Save Your Life with the 4 Thieves Vinegar Collective [video]

Overall reaction to the talk / project

• Some commenters like the spirit: reclaiming autonomy from a hostile healthcare system, especially in the US.
• Others think the project is mostly performance art or an “art project” that overclaims what is realistically possible.
• A linked critique from a professional chemist is seen by some as accurate but “smug” and tone‑deaf, by others as a needed reality check.

Feasibility and scope of DIY drug production

• Skeptics emphasize: synthesis is hard; many drugs are not simple; issues include purity, by‑products, chirality (e.g., thalidomide example), process control, and access to precursors.
• Supporters argue the collective deliberately focuses on relatively simple, off‑patent or price‑gouged drugs (e.g., Hep C cures, EpiPen components) as proofs of concept.
• Disagreement over how representative these examples are: some see “cherry‑picking,” others say a proof of concept is still valid even if limited.

Safety, waste, and regulation

• Concerns: “oops, poison” scenarios, MPTP‑type disasters, environmental waste disposal, effects on neighbors, and counterfeit/impure batches.
• Some note DIY communities and prominent chemistry YouTubers discuss safe waste handling extensively.
• Debate over laws: most places criminalize unlicensed distribution and some precursors, but generally not self‑consumption; some argue these laws are “written in blood,” others see monopoly protection.

Economic and political context

• Strong frustration at US healthcare: insurance denials, price‑gouging (Shkreli‑type cases), drug shortages, and people literally dying for lack of access.
• Arguments that much pharma R&D is publicly funded, so IP‑based scarcity and high prices are illegitimate.
• Counter‑arguments: patents and profits also fund failed drug candidates; removing IP might halt new drug development unless replaced by strong public funding.

Use cases and gray/black‑market practice

• Mentioned DIY or gray‑market areas: abortion pills, trans HRT and blockers, niche orphan drugs (e.g., trientine), Hep C cures, long‑COVID protocols, modafinil shortages.
• Some see DIY as a last‑resort survival tactic in hostile jurisdictions; others insist the real solution must be political (universal care, legal access), not technical workarounds.

Messaging, aesthetics, and information control

• Debate over their polished website: some distrust it as “marketing,” others say good design and political messaging are integral to empowering people and shifting discourse.
• One attempted Wikipedia addition about DIY Sovaldi synthesis was rejected as “borderline vandalism,” interpreted by some as risk‑avoidance toward pharma.
• The video briefly went 404; unclear if due to error, policy, or legal pressure; mirrors are shared.